Our Collaborators
Endurion Therapeutics LLC, collaborates with experts in oncology and pulmonary disease with our lead compound, ORIN1001.
Investors Welcome
Endurion Therapeutics LLC, is actively seeking investors for Phase 2 trials in oncology, IPF, and other serious diseases with ORIN1001.
COLLABORATORS
Dr. Mothaffar Rimawi
Medical Director of the Lester and Sue Smith Breast Center; Baylor College of Medicine, Houston Texas
Dr. Juan Cubillos-Ruiz
Professor of Microbiology and Immunology, Weill Cornell Medicine
Dr. Xi Chen
Assistant Professor, MD Anderson, Houston Texas
Dr. Afshin Somali
Professor, University of Galway, Ireland
Dr. Fahri Saatclogui
Professor for Molecular and Cell Biology, University of Oslo, Norway
Dr. Timothy Blackwell
Professor, Vanderbilt University, Nashville, Tennessee
Dr. Kenneth Anderson
Dana Farber Canter; Program Director, Jerome Lipper Multiple Myeloma Center; Kraft Family Professor of Medicine, Harvard Medical School
Dr. Eric Chevet
Research Director, French National Institute for Health and Medical Research (Inserm)